Investigators at Catholic University of Korea Report Findings in Factor Xa Inhibitors (Heparin-calibrated Anti-factor Xa Assay for the Measurement of Direct Anticoagulants Such As Apixaban, Rivaroxaban, and Edoxaban).

MLA

“Investigators at Catholic University of Korea Report Findings in Factor Xa Inhibitors (Heparin-Calibrated Anti-Factor Xa Assay for the Measurement of Direct Anticoagulants Such As Apixaban, Rivaroxaban, and Edoxaban).” Drug Week, Nov. 2024, p. 255. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=180740225&authtype=sso&custid=ns315887.

APA

Investigators at Catholic University of Korea Report Findings in Factor Xa Inhibitors (Heparin-calibrated Anti-factor Xa Assay for the Measurement of Direct Anticoagulants Such As Apixaban, Rivaroxaban, and Edoxaban). (2024). Drug Week, 255.

Chicago

“Investigators at Catholic University of Korea Report Findings in Factor Xa Inhibitors (Heparin-Calibrated Anti-Factor Xa Assay for the Measurement of Direct Anticoagulants Such As Apixaban, Rivaroxaban, and Edoxaban).” 2024. Drug Week, November, 255. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=180740225&authtype=sso&custid=ns315887.